A share price of CalciMedica Inc [CALC] is currently trading at $6.59, up 15.01%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The CALC shares have gain 7.50% over the last week, with a monthly amount glided 53.61%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
CalciMedica Inc experienced fluctuations in its stock price throughout the past year between $1.42 and $7.20. Currently, Wall Street analysts expect the stock to reach $266 within the next 12 months. CalciMedica Inc [NASDAQ: CALC] shares were valued at $6.59 at the most recent close of the market. An investor can expect a potential return of 3936.42% based on the average CALC price forecast.
Analyzing the CALC fundamentals
Gross Profit Margin for this corporation currently stands at 0.02% with Operating Profit Margin at -415.13%, Pretax Profit Margin comes in at -384.33%, and Net Profit Margin reading is -384.33%. To continue investigating profitability, this company’s Return on Assets is posted at -1.55, Equity is -2.96 and Total Capital is -2.22.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 5.94 points at the first support level, and at 5.30 for the second support level. However, for the 1st resistance point, the stock is sitting at 6.99, and for the 2nd resistance point, it is at 7.40.
Ratios To Look Out For
To put it in perspective, the Current Ratio for CalciMedica Inc [NASDAQ:CALC] is 4.04. As well, the Quick Ratio is 4.04, while the Cash Ratio is 1.49.
Transactions by insiders
Recent insider trading involved Roberts Eric W, CHIEF BUSINESS OFFICER, that happened on Sep 18 ’25 when 2500.0 shares were purchased. CHIEF BUSINESS OFFICER, Roberts Eric W completed a deal on Sep 15 ’25 to buy 3400.0 shares. Meanwhile, CHIEF BUSINESS OFFICER Roberts Eric W bought 5000.0 shares on Sep 12 ’25.
